๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

20 recruiting trials

for Recurrent Glioblastoma IDH Wildtype

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rฮฑ2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas NCT07544992Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Autologous Anti-EGFR/Anti-IL13Ralpha2 CAR T-cells, Biopsy Procedure, Biospecimen Collection, Echocardiography Test, FDGโ€ฆ Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma NCT07416188Phase 1, Phase 21 site๐Ÿ“ Bethesda National Institute of Neurological Disorders and Stroke (NIโ€ฆ ยท Tests: LMP744, Conventional Surgery or Biopsy A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma NCT06552260EARLY Phase 13 sites๐Ÿ“ Boston๐Ÿ“ Boston๐Ÿ“ Boston Ugonma Chukwueke ยท Tests: Troriluzole Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma NCT06410248Phase 11 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Magnetic Resonance Imaging, Questionnaire Administration, Resection, Temozolomide Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment NCT05432804Phase 1, Phase 239 sites๐Ÿ“ Phoenix๐Ÿ“ Duarte๐Ÿ“ Irvine National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Magnetic Resonance Imaging, Placebo Administration, Selinexor, Temozolomide [177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma NCT07655869EARLY Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing Tiantan Hospital ยท Tests: [177Lu]Lu-DOTA-EB-RGD2 The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma NCT06273176n/a8 sites๐Ÿ“ San Francisco๐Ÿ“ Boston๐Ÿ“ Leuven Erasmus Medical Center ยท Tests: Awake mapping under local anesthesia, Asleep mapping under general anesthesia, Resection under general anesthesia withoโ€ฆ TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0) NCT07668869NA1 site๐Ÿ“ Bydgoszcz Prof. Franciszek Lukaszczyk Memorial Oncology Center ยท Tests: Tumor Treating Fields (TTFields), FET-PET-Guided Stereotactic Radiosurgery Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma NCT07648823EARLY Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing Tiantan Hospital ยท Tests: [177Lu]Lu-XT771 GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma NCT07301268Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-102, Computed Tomography, Echocardiography Test,โ€ฆ Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy NCT05789394Phase 11 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Allogeneic Adipose-derived Mesenchymal Stem Cells, Biospecimen Collection, Craniotomy, Magnetic Resonance Imaging, Ommaโ€ฆ ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial NCT07089641Phase 12 sites๐Ÿ“ Los Angeles๐Ÿ“ New York Jonsson Comprehensive Cancer Center ยท Tests: Biospecimen Collection, Echocardiography Test, EGFR Inhibitor ERAS-801, Fludeoxyglucose F-18, Magnetic Resonance Imaging Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) NCT07733674Phase 11 site๐Ÿ“ Houston Radiomedix, Inc. ยท Tests: 203Pb-RMX-VHPIB injection, SPECT/CT Imaging A Clinical Trial of P134 Cells in Recurrent Glioblastoma NCT07318818Phase 1, Phase 21 site๐Ÿ“ Beijing Tasly Pharmaceutical Group Co., Ltd ยท Tests: P134 cell injection A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma NCT05765812Phase 1, Phase 216 sites๐Ÿ“ Chicago๐Ÿ“ New York๐Ÿ“ New York Debiopharm International SA ยท Tests: Debio 0123, Temozolomide, Radiotherapy Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma NCT06430424n/a1 site๐Ÿ“ Bordeaux University Hospital, Bordeaux ยท Tests: Relapsed glioblastoma D2C7-IT + 2141-V11 Combination Post-resection in rGBM NCT06455605Phase 11 site๐Ÿ“ Durham Darell Bigner ยท Tests: D2C7-IT, 2141 V11 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma NCT06860594Phase 143 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ La Jolla National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Intensity-Modulated Radiation Therapy, Magnetic Resonance Imaging, Triapine The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) NCT06283927n/a8 sites๐Ÿ“ San Francisco๐Ÿ“ Boston๐Ÿ“ Leuven Jasper Gerritsen ยท Tests: Re-resection, Temozolomide, Lomustine, Re-irradiation, Experimental therapy A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma NCT03970447Phase 2, Phase 363 sites๐Ÿ“ Birmingham๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Global Coalition for Adaptive Research ยท Tests: Temozolomide, Lomustine, Regorafenib, Radiation, Paxalisib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy